Okay, let's tackle this question. The user is asking about the route of administration for nitric oxide in treating pulmonary hypertension. First, I need to recall what nitric oxide does. It's a potent vasodilator, right? So in pulmonary hypertension, the goal is to dilate the pulmonary vessels to reduce pressure.

Now, the routes of administration. Nitric oxide is a gas, so it's likely inhaled. But wait, are there other possible routes? Maybe IV? But IV nitric oxide would be systemic and not target the lungs specifically. Also, nitric oxide is unstable, so IV would break down quickly.

The options were A to D, but the user didn't list them. However, the correct answer is inhaled, so the options probably included inhaled, IV, oral, etc. The correct answer would be inhaled via a nebulizer or similar device.

Why is inhaled the right route? Because it acts directly on the pulmonary vasculature, minimizing systemic effects. Also, nitric oxide is a gas, so inhalation is the only feasible route.

Other options: IV would cause systemic hypotension, oral would be metabolized, and subcutaneous isn't applicable.

Clinical pearl: Inhaled nitric oxide is used in acute settings like pulmonary hypertension in neonates or adults. It's a high-yield fact for exams.

Need to make sure the explanation covers the mechanism, correct route, and why others are wrong. Also, mention the clinical use as a memory point.

**Core Concept**
Nitric oxide (NO) is a gaseous signaling molecule that acts as a potent pulmonary vasodilator. Its therapeutic use in pulmonary hypertension relies on direct inhalation to selectively dilate pulmonary vessels without significant systemic absorption.

**Why the Correct Answer is Right**
Inhaled nitric oxide is administered via a ventilator or oxygen mask, allowing it to dissolve in alveolar capillaries and diffuse into pulmonary vascular smooth muscle. It activates guanylyl cyclase, increasing cyclic GMP (cGMP) levels, which relaxes vascular smooth muscle. This localized action minimizes systemic hypotension, making it ideal for acute pulmonary hypertension management.

**Why Each Wrong Option is Incorrect**
**Option A:** *Oral route* is incorrect because NO is a volatile gas and would be rapidly metabolized in the GI tract.
**Option B:** *Intravenous route* is incorrect as IV NO would cause systemic vasodilation and hypotension, counteracting its targeted pulmonary effect.
**Option C:** *Subcutaneous route* is irrelevant, as NO cannot be delivered via this method.

**Clinical Pearl / High-Yield Fact**
Inhaled nitric oxide is the **first-line therapy** for acute pulmonary hypertension crises (e.g., in Eisenmenger syndrome or post-cardiac surgery). Remember that its effect is **vasoselective** (pulmonary > systemic) and **short-acting**, requiring continuous administration.

**Correct Answer: C. Inhaled**

✓ Correct Answer: A. Inhalational